GE gets EU ok to buy Abbott's diagnostics units
This article was originally published in Clinica
GE's proposed $8.13bn cash acquisition of Abbott's lab and point-of-care diagnostics businesses has received the greenlight from EU regulatory approval. The European Commission said in a statement that after careful examination, it concluded that the transaction would not significantly impede effective competition in the European Economic Area (EEA) or any substantial part of it". The deal has already been approved by the US Federal Trade Commission, but requires further clearances from other regions, a GE spokesperson told Clinica.
You may also be interested in...
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.